Literature DB >> 1475361

Effect of dose rate on the survival of irradiated human skin fibroblasts.

H Nagasawa1, J B Little, N M Tsang, E Saunders, J Tesmer, G F Strniste.   

Abstract

The survival of cells in density-inhibited, confluent cultures maintained at 37 degrees C was examined following exposure to 137Cs gamma rays at low dose rates (0.023 or 0.153 Gy/h) or to 60Co gamma rays at a single high dose rate (0.70-0.75 Gy/min). Cells from an ataxia telangiectasia (AT) homozygote showed no dose-rate effect, whereas a three- to fivefold increase in D0 was observed for all other cell strains exposed at low dose rates. The magnitude of the dose-rate effect did not differ significantly among cells from persons with hereditary retinoblastoma, basal cell nevus syndrome, or AT-heterozygote compared with normal cell strains, and was not related to the size of the shoulder (extrapolation number) of the survival curve. Furthermore, no differences in the capacity for the repair of potentially lethal damage during confluent holding were observed among these latter cell strains.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1475361

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  3 in total

1.  Cellular Senescence - its role in cancer and the response to ionizing radiation.

Authors:  Rebecca J Sabin; Rhona M Anderson
Journal:  Genome Integr       Date:  2011-08-11

2.  Differential radiosensitivity phenotypes of DNA-PKcs mutations affecting NHEJ and HRR systems following irradiation with gamma-rays or very low fluences of alpha particles.

Authors:  Yu-Fen Lin; Hatsumi Nagasawa; John B Little; Takamitsu A Kato; Hung-Ying Shih; Xian-Jin Xie; Paul F Wilson; John R Brogan; Akihiro Kurimasa; David J Chen; Joel S Bedford; Benjamin P C Chen
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

3.  Isolated Clones of a Human Colorectal Carcinoma Cell Line Display Variation in Radiosensitivity Following Gamma Irradiation.

Authors:  Rhea Desai; Colin Seymour; Carmel Mothersill
Journal:  Dose Response       Date:  2022-09-10       Impact factor: 2.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.